Table 1 Participants’ descriptive data
From: Evaluation of zonulin levels in patients with migraine
n (%) | ||
|---|---|---|
Gender(n = 80) | Male | 19 (23.8) |
Female | 61 (76.3) | |
Age(n = 80) | Mean ± SD | 32.06 ± 6.99 |
Median (Min-Max) | 32 (20–46) | |
Zonulin (ng/mL)(n = 80) | Mean ± SD | 27.47 ± 7.57 |
Median (Min-Max) | 28.6 (6.04–39.5) | |
Disease duration (years)(n = 40) | Mean ± SD | 7.90 ± 5.56 |
Median (Min-Max) | 6 (1–20) | |
Attack frequency (/month) (n = 40) | Mean ± SD | 5.57 ± 5.28 |
Median (Min-Max) | 3 (1–20) | |
Attack duration (hours)(n = 40) | Mean ± SD | 25.42 ± 25.12 |
Median (Min-Max) | 24 (1–96) | |
VAS score(n = 40) | Mean ± SD | 8.30 ± 1.60 |
Median (Min-Max) | 8 (4–10) | |
Comorbidity(n = 40) | 14 (35.0) | |
Prophylactic treatment(n = 40) | 4 (10.0) |